Results 331 to 340 of about 106,358 (395)

Low Dose Methotrexate Has Divergent Effects on Cycling and Resting Human Hematopoietic Stem and Progenitor Cells

Clinical and Translational Science, Volume 18, Issue 5, May 2025.
ABSTRACT Low dose methotrexate (LD‐MTX) remains the gold standard in rheumatoid arthritis (RA) therapy. Multiple mechanisms on a variety of immune cells contribute to the anti‐inflammatory effects of LD‐MTX. Inflammatory signaling is deeply implicated in hematopoiesis by regulating hematopoietic stem and progenitor cell (HSPC) fate decisions; raising ...
Maximilien Lora, H. A. Ménard, Anastasia Nijnik, David Langlais, Marie Hudson, Inés Colmegna   +5 more
wiley   +1 more source

Factors influencing therapeutic efficacy of denosumab against osteoporosis in systemic lupus erythematosus. [PDF]

Lupus Sci Med
Yang J, Park Y, Lee JJ, Kwok SK, Ju JH, Kim WU, Park SH.   +6 more
europepmc   +1 more source

Clinical features, treatment options and outcomes in primary cutaneous B‐cell lymphomas: a real‐world, multicenter, retrospective study

International Journal of Dermatology, Volume 64, Issue 5, Page 882-889, May 2025.
Clinical features, treatment options and outcomes in PCBCL. Abstract Background Primary cutaneous B‐cell lymphomas (PCBCLs) are rare cutaneous neoplasms with limited literature regarding treatment options and associated treatment outcomes. This study aimed to investigate and present real‐world treatment outcomes in patients with PCBCLs.
Vasiliki Nikolaou, Ioannis‐Alexios Koumprentziotis, Evangelia Papadavid, Aikaterini Patsatsi, Stavrianna Diavati, Antonios Tsimpidakis, Sabine Kruger‐Krasagakis, Aikaterini Doxastaki, Leonidas Marinos, Stella Kaliampou, Maria Gerochristou, Marios Koumourtzis, Vasiliki Pappa, Efrosini Kypraiou, Vassilis Kouloulias, Konstantinos Angelopoulos, Alexandros Machairas, Theodoros Vassilakopoulos, Vasiliki Papadopoulou, Athanasios Tsamaldoupis, Elisavet Georgiou, Triantafyllia Koletsa, Alexander Stratigos, Marina Siakantaris, Maria Angelopoulou   +24 more
wiley   +1 more source

Dermatologic manifestations of hereditary hemochromatosis: A systematic review

Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 5, Page 976-986, May 2025.
Abstract Hereditary hemochromatosis (HH) is a genetic disorder leading to excessive iron absorption, impacting multiple organs, notably the skin, nails and mucosae. The objective of this study is to elucidate the dermatologic manifestations, associated symptoms, pathophysiology and management recommendations of HH.
Hossein Akbarialiabad, Parnian Jamshidi, Jeffrey P. Callen, Dédée F. Murrell   +3 more
wiley   +1 more source

Breastfeeding in women with juvenile idiopathic arthritis: results from a Norwegian quality register. [PDF]

BMC Pregnancy Childbirth
Birkeland T, Størdal Å, Skorpen CG, Koksvik HS, Wallenius M.   +4 more
europepmc   +1 more source

Plasma cell‐directed therapies induce profound clinical and durable responses in patients with severe or relapsed/refractory scleromyxedema

Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 5, Page 1011-1016, May 2025.
In severe forms of monoclonal gammapathy associated with scleromyxoedema with dermatoneuro syndrome and/or cardiac involvement, deep and durable responses allowing IVIG withdrawal could be achieved using anti‐plasma cell therapy, including Imids, anti‐CD38 or proteasome inhibitors. Abstract Background Scleromyxedema (SM) is a rare skin disorder related
F. Theves, C. Lahuna, T. Mahévas, S. Harel, B. Royer, V. Lemiale, A. Brignier, N. Parquet, M. Jachiet, J.‐D. Bouaziz, D. Elessa, B. Arnulf, A. Talbot   +12 more
wiley   +1 more source

Efficacy and safety of CFTR modulators in patients with interstitial lung disease caused by ABCA3 transporter deficiency. [PDF]

ERJ Open Res
Le Brun M, Nathan N, Louvrier C, Legendre M, Feuillet S, Frija-Masson J, Onanga M, Morer L, Debray MP, Fajac I, Burgel PR, Marchand-Adam S, Crestani B, Borie R.   +13 more
europepmc   +1 more source

THE EFFICACY AND SAFETY OF IMMARD (HYDROXYCHLOROQUINE) IN RHEUMATOID ARTHRITIS ACCORDING TO THE DATA OF AN OPEN-LABEL UNCONTROLLED TRIAL IN OUTPATIENT PRACTICE

, 2012
R M Balabanova, D A Gukasyan, E. L. Shakhramanova, D. V. Goryachev   +3 more
openalex   +1 more source

New Diagnosis of Lupus Nephritis in the Third Trimester—A Case Report

Nephrology, Volume 30, Issue 5, May 2025.
ABSTRACT New‐onset lupus nephritis (LN) poses a diagnostic and management challenge during pregnancy. This is more pertinent in the indigenous population, where the prevalence is higher, and the clinical phenotype tends to be more severe. We report the case of a 30‐year‐old G3P2 indigenous female, living in remote Queensland, with a late presentation ...
Umesha Pathmanathan, Sivasaaini Sivakumaran, Jade Eccles‐Smith, Ann‐Maree Craven, Jill Parkes Smith, Prianka Puri, Kirsten Hepburn   +6 more
wiley   +1 more source